Matsumoto Shohei, Shamloo Mehrdad, Matsumoto Eriko, Isshiki Atsushi, Wieloch Tadeusz
Laboratory for Experimental Brain Research, Wallenberg Neuroscience Center, Lund University Hospital, Lund, Sweden.
J Cereb Blood Flow Metab. 2004 Jan;24(1):54-61. doi: 10.1097/01.WCB.0000095920.70924.F5.
The levels of protein kinase C-gamma (PKC-gamma ) and the calcium/calmodulin-dependent kinase II-alpha (CaMKII-alpha) were measured in crude synaptosomal (P2), particulate (P3), and cytosolic (S3) fractions of the neocortex of rats exposed to 1-hour and 2-hour middle cerebral artery occlusion (MCAO) and 2-hour MCAO followed by 2-hour reperfusion. During MCAO, PKC levels increased in P2 and P3 in the most severe ischemic areas concomitantly with a decrease in S3. In the penumbra, PKCgamma decreased in S3 without any significant increases in P2 and P3. Total PKC-gamma also decreased in the penumbra but not in the ischemic core, suggesting that the protein is degraded by an energy-dependent mechanism, possibly by the 26S proteasome. The CaMKII-alpha levels increased in P2 but not P3 during ischemia and reperfusion in all ischemic regions, particularly in the ischemic core. Concomitantly, the levels in S3 decreased by 20% to 40% in the penumbra and by approximately 80% in the ischemic core. There were no changes in the total levels of CaMKII-alpha during MCAO. The authors conclude that during and after ischemia, PKC and CaMKII-alpha are translocated to the cell membranes, particularly synaptic membranes, where they may modulate cellular function, such as neurotransmission, and also affect cell survival. Drugs preventing PKC and/or CaMKII-alpha translocation may prove beneficial against ischemic cell death.
在暴露于1小时和2小时大脑中动脉闭塞(MCAO)以及2小时MCAO后再灌注2小时的大鼠新皮质的粗制突触体(P2)、微粒体(P3)和胞质(S3)组分中,测量了蛋白激酶C-γ(PKC-γ)和钙/钙调蛋白依赖性激酶II-α(CaMKII-α)的水平。在MCAO期间,最严重缺血区域的P2和P3中PKC水平升高,同时S3中PKC水平降低。在半暗带,S3中的PKCγ降低,而P2和P3中没有显著升高。半暗带中的总PKC-γ也降低,但缺血核心区没有降低,这表明该蛋白通过能量依赖机制降解,可能是通过26S蛋白酶体。在所有缺血区域,尤其是缺血核心区,缺血和再灌注期间P2中的CaMKII-α水平升高,而P3中没有升高。与此同时,半暗带中S3的水平降低了20%至40%,缺血核心区降低了约80%。MCAO期间CaMKII-α的总水平没有变化。作者得出结论,在缺血期间和之后,PKC和CaMKII-α易位至细胞膜,尤其是突触膜,在那里它们可能调节细胞功能,如神经传递,也影响细胞存活。预防PKC和/或CaMKII-α易位的药物可能对缺血性细胞死亡有益。